Table 5a
|
MM
|
endomembrane system
|
3.8E-09
|
EC
|
extracellular region
|
1.6E-08
|
MM
|
Golgi apparatus
|
2.4E-07
| |
ectoderm development
|
3.3E-07
|
MM
|
cell fraction
|
1.0E-05
|
IM
|
response to wounding
|
4.3E-07
|
CC
|
cell division
|
2.1E-05
|
EC
|
extracellular region part
|
1.3E-06
|
MM
|
organelle membrane
|
3.1E-05
|
EC
|
extracellular space
|
2.4E-06
|
MM
|
nuclear envelope-endoplasmic reticulum network
|
5.9E-05
| |
epidermis development
|
8.4E-06
|
R
|
response to organic substance
|
8.1E-05
|
CC
|
regulation of cell proliferation
|
1.1E-05
|
MM
|
endoplasmic reticulum membrane
|
1.0E-04
|
CC
|
regulation of smooth muscle cell proliferation
|
6.5E-05
|
CC
|
Mitosis
|
1.1E-04
|
IM
|
wound healing
|
7.3E-05
|
MM
|
1p22.1
|
1.5E-04
|
CC
|
positive regulation of smooth muscle cell proliferation
|
1.9E-04
|
Table 5b
|
CC
|
cell cycle
|
3.1E-04
|
IM
|
defense response
|
5.9E-04
|
M_l
|
steroid metabolic process
|
4.3E-04
|
IM
|
inflammatory response
|
9.2E-04
|
| | |
O
|
epidermal growth factor receptor binding
|
2.5E-04
|
| | |
O
|
ErbB signaling pathway
|
4.2E-04
|
Genes overexpressed in resistant cells
|
Table 5c
| |
EGFR Binding ligands
|
ErbB sig pathway
|
amphiregulin; amphiregulin B
|
Cas-Br-M ecotropic retroviral transforming sequence c
|
epidermal growth factor receptor
|
amphiregulin; amphiregulin B
|
Epiregulin
|
epidermal growth factor receptor
|
heparin-binding EGF-like growth factor
|
epiregulin
|
|
heparin-binding EGF-like growth factor
|
|
transforming growth factor, alpha
|
|
v-erb-b2 oncogene homolog 3
|